首页> 美国卫生研究院文献>Translational Psychiatry >Chromatin remodeling — a novel strategy to control excessive alcohol drinking
【2h】

Chromatin remodeling — a novel strategy to control excessive alcohol drinking

机译:染色质重塑-控制过量饮酒的新策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Harmful excessive use of alcohol has a severe impact on society and it remains one of the major causes of morbidity and mortality in the population. However, mechanisms that underlie excessive alcohol consumption are still poorly understood, and thus available medications for alcohol use disorders are limited. Here, we report that changing the level of chromatin condensation by affecting DNA methylation or histone acetylation limits excessive alcohol drinking and seeking behaviors in rodents. Specifically, we show that decreasing DNA methylation by inhibiting the activity of DNA methyltransferase (DNMT) with systemic administration of the FDA-approved drug, 5-azacitidine (5-AzaC) prevents excessive alcohol use in mice. Similarly, we find that increasing histone acetylation via systemic treatment with several histone deacetylase (HDAC) inhibitors reduces mice binge-like alcohol drinking. We further report that systemic administration of the FDA-approved HDAC inhibitor, SAHA, inhibits the motivation of rats to seek alcohol. Importantly, the actions of both DNMT and HDAC inhibitors are specific for alcohol, as no changes in saccharin or sucrose intake were observed. In line with these behavioral findings, we demonstrate that excessive alcohol drinking increases DNMT1 levels and reduces histone H4 acetylation in the nucleus accumbens (NAc) of rodents. Together, our findings illustrate that DNA methylation and histone acetylation control the level of excessive alcohol drinking and seeking behaviors in preclinical rodent models. Our study therefore highlights the possibility that DNMT and HDAC inhibitors can be used to treat harmful alcohol abuse.
机译:有害过度使用酒精对社会造成严重影响,它仍然是人口发病和死亡的主要原因之一。然而,对于过量饮酒的机制仍知之甚少,因此,针对酒精使用障碍的可用药物受到限制。在这里,我们报告说,通过影响DNA甲基化或组蛋白乙酰化来改变染色质缩合水平,限制了过量饮酒和啮齿动物的行为。具体来说,我们显示通过系统批准FDA批准的药物5-氮杂胞苷(5-AzaC)抑制DNA甲基转移酶(DNMT)的活性来降低DNA甲基化,可以防止小鼠过度饮酒。同样,我们发现通过使用几种组蛋白脱乙酰基酶(HDAC)抑制剂进行全身治疗来提高组蛋白乙酰化程度可减少小鼠暴饮酒般的饮酒。我们进一步报告说,FDA批准的HDAC抑制剂SAHA的全身给药抑制了大鼠寻求酒精的动机。重要的是,DNMT和HDAC抑制剂的作用都是针对酒精的,因为未观察到糖精或蔗糖摄入量的变化。根据这些行为研究结果,我们证明了过量饮酒会增加DNMT1的水平并减少啮齿动物伏隔核(NAc)中的组蛋白H4乙酰化。总之,我们的发现表明,在临床前啮齿动物模型中,DNA甲基化和组蛋白乙酰化控制了过量饮酒和寻求行为的水平。因此,我们的研究强调了DNMT和HDAC抑制剂可用于治疗有害酒精滥用的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号